의료 자동화 시장 : 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the medical automation market size is expected to increase from USD 23.27 billion in 2025 to USD 25.21 billion in 2026 and reach USD 37.65 billion by 2031, growing at a CAGR of 8.35% over 2026-2031.

This report is Segmented by Component (Hardware, Software, Services), Application Type (Imaging Automation, Therapeutic Automation, Laboratory and Pharmacy Automation), End Use (Hospitals and Diagnostic Centers, Research Laboratories, Pharmacies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Medical Automation Market Trends and Insights

Workforce Shortages in Clinical Operations

Workforce shortages have become a structural demand base for the medical automation market, especially where hospitals need stable care delivery with fewer available clinicians. Health systems are now treating automation purchases as protection against staffing risk rather than as optional efficiency projects. In the United States, workforce projections continue to point to physician and nursing shortfalls through the next decade, which keeps automation high on executive agendas. That shift changes the budget conversation because automation is increasingly reviewed alongside resilience and service continuity needs. Vendors that present their platforms as staffing support tools are gaining better traction in the medical automation market than vendors that position them only as productivity upgrades.

AI-Enabled Workflow Orchestration Across Imaging, Lab, and Surgery

AI orchestration is moving the medical automation market beyond single-use tools and toward systems that manage multiple clinical workflows together. Vendors are using this shift to build recurring revenue through software, analytics, and enterprise workflow management rather than relying only on device sales. Roche stated that its navify digital ecosystem exceeded 1,500 clinical placements by 2025, while GE HealthCare's Edison AI Orchestrator is designed to unify AI applications across radiology workflows. A 2026 Nature paper described autonomous medical AI agents that can interface with EHR environments through FHIR standards to coordinate scheduling, diagnostics, and documentation. Vendors already present across imaging, laboratory, and surgical settings are better placed to capture this demand in the medical automation market because orchestration value rises with integration breadth.

High Capital Intensity for Integrated Automation Suites

High capital intensity remains the clearest near-term limit on the medical automation market, especially for community, rural, and mid-tier hospitals. The American Hospital Association reported that hospital expenses rose 5.1% in 2024 while general inflation was 2.9%, and it also noted that the average age of hospital plant infrastructure increased more than 10% over the prior 2 years. That pressure reduces the room for large automation purchases even when clinical need is clear. It also pushes smaller providers toward phased deployments, narrower scopes, or deferred decisions instead of full integrated suites. Vendors are responding with subscription and managed service models, but the medical automation market still faces slower decision cycles where procurement rules are strict and capital availability is weak.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of Surgical and Laboratory Automation
2. Rising Error Sensitivity in Medication and Procedure Workflows
3. Interoperability Friction With Legacy Hospital Systems

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Hardware held 52.31% of the medical automation market share in 2025, reflecting the high value of robotic surgical systems, automated dispensing cabinets, and high-throughput laboratory instruments being installed across care settings. Intuitive Surgical placed 1,721 da Vinci systems in 2025, and its installed base exceeded 11,100 systems by year-end, which shows how hardware continues to define revenue scale in the medical automation market. These placements build the installed foundation that supports later software, maintenance, and analytics revenue. Software remains important because providers want interoperable control layers that can manage automation across multi-site networks.

Services is the fastest-growing component of the medical automation market at a CAGR of 10.38% through 2026 to 2031, showing where post-deployment revenue is expanding fastest. Managed services, remote monitoring, AI analytics, and platform subscriptions are growing because vendors are attaching these offerings to installed hardware bases. This model improves retention and margin quality for suppliers while giving providers a way to expand functionality after initial deployment. That keeps services central to future value capture in the medical automation industry as health systems look for support beyond the hardware layer.

Complete Report Scope:

• By Component
  • Hardware
  • Software
  • Services
• By Application Type
  • Imaging Automation
  • Therapeutic Automation
  • Laboratory and Pharmacy Automation
  • Other Application Types
• By End Use
  • Hospitals and Diagnostic Centers
  • Research Laboratories and Institutes
  • Pharmacies
  • Other End Uses
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 42.62% of the medical automation market share in 2025, which kept it as the largest regional contributor on the strength of hospital capital capacity, established reimbursement, and a deep installed base. The United States remains the main regional driver because large health systems continue to fund robotic surgery, imaging automation, and pharmacy automation even as smaller hospitals stay more selective. FDA cybersecurity guidance and the QMSR now shape procurement more directly because connected devices need stronger quality, software, and lifecycle documentation. Europe remains an advanced but uneven region, with Western Europe showing stronger adoption conditions than Southern and Eastern Europe. BD's April 2026 Pyxis Pro launch, the March 2026 BD and Sinteco partnership, the March 2026 IMARA initiative in Strasbourg, and Ireland's national CareFlow Pharmacy rollout all show that medication, logistics, and operating room automation continue to gain institutional backing across Europe.

Asia-Pacific is the fastest-growing regional slice of the medical automation market, with a CAGR of 11.15% through 2026 to 2031. The region benefits from greenfield hospital investment, state-backed modernization programs, and expanding domestic medical technology capabilities. China held the largest regional share in 2025, supported by smart hospital spending, AI-enabled diagnostics initiatives, and local robotics manufacturing, while India is the fastest-growing country market within the region. Those conditions are widening adoption beyond imported surgical systems and toward broader automation stacks across modernizing hospital networks. Japan remains a mature high-value market for laboratory and pharmacy automation, which adds stability to regional demand while newer systems scale elsewhere.

The Middle East and Africa remains earlier stage in the medical automation market, but GCC countries are actively linking hospital automation spending to wider health system transformation agendas. Saudi Arabia and the UAE are leading that regional activity, while South Africa remains a key anchor in sub-Saharan demand for laboratory and imaging automation. South America is led by Brazil and followed by Argentina, where premium private hospital networks are using robotic surgery and laboratory automation as competitive tools despite currency and reimbursement pressure. These regions are smaller today, but they extend the long-run addressable base of the medical automation market as infrastructure and capital access improve.

1. Accuray
2. Baxter
3. Beckton Dickinson
4. Boston Scientific
5. Danaher
6. GE HealthCare Technologies Inc.
7. Intuitive Surgical, Inc.
8. Johnson & Johnson
9. Koninklijke Philips
10. Medtronic
11. Olympus
12. Omnicell
13. Oracle Health
14. Roche
15. Siemens Healthineers
16. Stryker
17. Swisslog Healthcare
18. Tecan Group
19. Terumo

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Workforce Shortages in Clinical Operations
  • 4.2.2 Rising Error Sensitivity in Medication and Procedure Workflows
  • 4.2.3 AI-Enabled Workflow Orchestration Across Imaging, Lab, and Surgery
  • 4.2.4 Unplanned Automation Retrofit Demand in Aging Hospital Infrastructure
  • 4.2.5 Expansion of Surgical and Laboratory Automation
  • 4.2.6 Cost Pressure on Healthcare Providers
• 4.3 Market Restraints
  • 4.3.1 High Capital Intensity for Integrated Automation Suites
  • 4.3.2 Interoperability Friction With Legacy Hospital Systems
  • 4.3.3 Clinical Validation and Medico-Legal Approval Lag
  • 4.3.4 Data Privacy, Cybersecurity, and Liability Concerns
• 4.4 Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Industry Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Component
  • 5.1.1 Hardware
  • 5.1.2 Software
  • 5.1.3 Services
• 5.2 By Application Type
  • 5.2.1 Imaging Automation
  • 5.2.2 Therapeutic Automation
  • 5.2.3 Laboratory and Pharmacy Automation
  • 5.2.4 Other Application Types
• 5.3 By End Use
  • 5.3.1 Hospitals and Diagnostic Centers
  • 5.3.2 Research Laboratories and Institutes
  • 5.3.3 Pharmacies
  • 5.3.4 Other End Uses
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market Level Overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.3.1 Accuray Incorporated
  • 6.3.2 Baxter International Inc.
  • 6.3.3 Becton, Dickinson and Company
  • 6.3.4 Boston Scientific Corporation
  • 6.3.5 Danaher Corporation
  • 6.3.6 GE HealthCare Technologies Inc.
  • 6.3.7 Intuitive Surgical, Inc.
  • 6.3.8 Johnson and Johnson
  • 6.3.9 Koninklijke Philips N.V.
  • 6.3.10 Medtronic plc
  • 6.3.11 Olympus Corporation
  • 6.3.12 Omnicell, Inc.
  • 6.3.13 Oracle Health
  • 6.3.14 Roche Diagnostics
  • 6.3.15 Siemens Healthineers AG
  • 6.3.16 Stryker Corporation
  • 6.3.17 Swisslog Healthcare
  • 6.3.18 Tecan Group Ltd.
  • 6.3.19 Terumo Corporation

7 Market Opportunities & Future Outlook

• 7.1 White-Space and Unmet-Need Assessment